Literature DB >> 27271551

Immunoglobulin G4 (IgG4)-positive plasma cell infiltration is associated with the clinicopathologic traits and prognosis of pancreatic cancer after curative resection.

Qiaofei Liu1, Zheyu Niu1, Yuan Li2, Mengyi Wang1, Boju Pan1, Zhaohui Lu2, Quan Liao3, Yupei Zhao4.   

Abstract

Interactions between pancreatic cancer cells and inflammatory cells play crucial roles in the biological behavior of pancreatic cancer. Abundant infiltration of immunoglobulin G4 (IgG4)-positive plasma cells in the pancreas is the most significant feature of autoimmune pancreatitis; however, the clinical significance of IgG4-positive plasma cell infiltration in pancreatic cancer has not previously been reported. Herein, we analyzed intratumoral and peritumoral infiltrations of IgG4-positive plasma cells in 95 pancreatic cancer cases after curative resection. The correlations between IgG4-positive plasma cell infiltration and the clinicopathologic traits and overall survival of pancreatic cancer were investigated. IgG4-positive plasma cells were found in 86 % of tumor tissue samples compared with 69 % of peritumoral tissue samples (P = 0.0063). The high-level infiltration of intratumoral IgG4-positive plasma cells was positively correlated with poor histological grade (P = 0.017). The high-level infiltration of intratumoral IgG4-positive plasma cells was significantly correlated with worse prognosis (P = 0.01) in multivariate analysis. We further found that intratumoral M2-polarized tumor-associated macrophages (TAMs) were positively, linearly correlated with IgG4-positive plasma cells. In conclusion, IgG4-positive plasma cell infiltration is correlated with the clinicopathologic traits and overall survival of pancreatic cancer. High-level intratumoral infiltration of IgG4-positive plasma cells is an independent predictor for poor overall survival in pancreatic cancer patients after curative resection. Intratumoral M2-polarized TAMs probably induce IgG4-positive plasma cells.

Entities:  

Keywords:  Clinicopathologic traits; IgG4-positive plasma cell; Overall survival; Pancreatic cancer; Prognosis; Tumor-associated macrophages

Mesh:

Substances:

Year:  2016        PMID: 27271551     DOI: 10.1007/s00262-016-1853-2

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  10 in total

Review 1.  Potential Roles of Peripheral Dopamine in Tumor Immunity.

Authors:  Xiang Zhang; Qiaofei Liu; Quan Liao; Yupei Zhao
Journal:  J Cancer       Date:  2017-08-25       Impact factor: 4.207

Review 2.  Review of primary sclerosing cholangitis with increased IgG4 levels.

Authors:  Charis D Manganis; Roger W Chapman; Emma L Culver
Journal:  World J Gastroenterol       Date:  2020-06-21       Impact factor: 5.742

Review 3.  The Role of IgG4 in the Fine Tuning of Tolerance in IgE-Mediated Allergy and Cancer.

Authors:  Rodolfo Bianchini; Sophia N Karagiannis; Galateja Jordakieva; Erika Jensen-Jarolim
Journal:  Int J Mol Sci       Date:  2020-07-16       Impact factor: 5.923

Review 4.  Tertiary lymphoid structures and B lymphocytes in cancer prognosis and response to immunotherapies.

Authors:  Jacquelot N; Tellier J; Nutt Sl; Belz Gt
Journal:  Oncoimmunology       Date:  2021-03-29       Impact factor: 8.110

5.  CT Image Changes of Severe Acute Pancreatitis Based on Smart Electronic Medical Augmented Reality in Nursing Practice.

Authors:  Defen Zhang; Shifang Mao; Siyou Lan; Chengli Zhou; Xiaoyan Liu
Journal:  J Healthc Eng       Date:  2021-04-26       Impact factor: 2.682

Review 6.  B-Lymphocytes in the Pathophysiology of Pancreatic Adenocarcinoma.

Authors:  Claudia Minici; Sabrina Testoni; Emanuel Della-Torre
Journal:  Front Immunol       Date:  2022-03-14       Impact factor: 7.561

7.  Tumor-infiltrating plasma cells are the promising prognosis marker for esophageal squamous cell carcinoma.

Authors:  Chengyun Yao; Hongliang Yu; Guoren Zhou; Jianhua Xu; Dayong Gu; Li Yin; Xia He; Hongping Xia
Journal:  Esophagus       Date:  2021-03-10       Impact factor: 4.230

Review 8.  The Use of Biomarkers in Early Diagnostics of Pancreatic Cancer.

Authors:  Lumir Kunovsky; Pavla Tesarikova; Zdenek Kala; Radek Kroupa; Petr Kysela; Jiri Dolina; Jan Trna
Journal:  Can J Gastroenterol Hepatol       Date:  2018-08-14

9.  Tumor size classification of the 8th edition of TNM staging system is superior to that of the 7th edition in predicting the survival outcome of pancreatic cancer patients after radical resection and adjuvant chemotherapy.

Authors:  Lin Cong; Qiaofei Liu; Ronghua Zhang; Ming Cui; Xiang Zhang; Xiang Gao; Junchao Guo; Menghua Dai; Taiping Zhang; Quan Liao; Yupei Zhao
Journal:  Sci Rep       Date:  2018-07-10       Impact factor: 4.379

Review 10.  IgE Antibodies: From Structure to Function and Clinical Translation.

Authors:  Brian J Sutton; Anna M Davies; Heather J Bax; Sophia N Karagiannis
Journal:  Antibodies (Basel)       Date:  2019-02-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.